ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RPID Rapid Micro Biosystems Inc

3.0381
0.7481 (32.67%)
After Hours
Last Updated: 23:56:52
Delayed by 15 minutes
Share Name Share Symbol Market Type
Rapid Micro Biosystems Inc NASDAQ:RPID NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.7481 32.67% 3.0381 2.96 3.04 3.06 2.3001 2.38 2,286,240 23:56:52

Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024

23/10/2024 9:45pm

GlobeNewswire Inc.


Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart


From Aug 2024 to Feb 2025

Click Here for more Rapid Micro Biosystems Charts.

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2024 financial results prior to the market open on Friday, November 1, 2024.

In conjunction with the release, the Company’s management team will host a webcast conference call beginning at 9:00 a.m. ET on Friday, November 1, 2024. The live audio webcast will be accessible on the Company’s website here and will be available for replay for one year from the webcast date.

About Rapid Micro BiosystemsRapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct System automates and modernizes the antiquated, manual MQC testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct System brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered in Lexington, Massachusetts and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands.

For more information, please visit www.rapidmicrobio.com or follow the Company on X (formerly known as Twitter) at @rapidmicrobio or on LinkedIn.

Investor Contact:
Michael Beaulieu, CFA
Vice President, Investor Relations and Corporate Communications
investors@rapidmicrobio.com

Media Contact:
media@rapidmicrobio.com

1 Year Rapid Micro Biosystems Chart

1 Year Rapid Micro Biosystems Chart

1 Month Rapid Micro Biosystems Chart

1 Month Rapid Micro Biosystems Chart

Your Recent History

Delayed Upgrade Clock